Discontinued Operations, Sale of Clinical Labs Business (Details) - USD ($) |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jul. 24, 2023 |
Jul. 31, 2023 |
Jul. 31, 2022 |
|
| Discontinued Operations, Sale of Clinical Labs Business [Abstract] | |||
| Aggregate purchase price | $ 113,250,000 | ||
| Transaction costs | $ 9,941 | ||
| Transaction fees and related | 7,238 | ||
| Performance bonuses to employees | 2,703 | ||
| Cash used in operation activities | 19,000,000,000 | $ 4,224 | |
| Cash used in investing activities | $ 101,300,000,000 | $ 815 | |
| X | ||||||||||
- Definition Amount of aggregate purchase price. No definition available.
|
| X | ||||||||||
- Definition Amount of transaction costs. No definition available.
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of transactions with related party during the financial reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|